| Stem definition | Drug id | CAS RN |
|---|---|---|
| histone N-methyltransferase inhibitors | 5724 | 1809336-39-7 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 26, 2022 | PMDA | DAIICHI SANKYO COMPANY, LIMITED |
None
None
None
None
None
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Relapsed or refractory T-cell leukemia-lymphoma | indication | 110007008 | DOID:5603 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Histone-lysine N-methyltransferase EZH2 | Enzyme | INHIBITOR | IC50 | 8.22 | SCIENTIFIC LITERATURE | ||||
| Histone-lysine N-methyltransferase EZH1 | Enzyme | INHIBITOR | IC50 | 8 | SCIENTIFIC LITERATURE |
| ID | Source |
|---|---|
| CHEMBL4597193 | ChEMBL_ID |
| 12282 | IUPHAR_LIGAND_ID |
| C5239419 | UMLSCUI |
| CHEMBL4594405 | ChEMBL_ID |
| 10747 | INN_ID |
| 126481870 | PUBCHEM_CID |
| D11551 | KEGG_DRUG |
| 60RD0234VE | UNII |
None